Spots Global Cancer Trial Database for mantle cell lymphomas
Every month we try and update this database with for mantle cell lymphomas cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Pembrolizumab in Patients Failing to Respond to or Relapsing After CAR T Cell Therapy for Relapsed or Refractory Lymphomas | NCT02650999 | CD19+ Diffuse L... Follicular Lymp... Mantle Cell Lym... | Pembrolizumab | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Pembrolizumab in Patients Failing to Respond to or Relapsing After CAR T Cell Therapy for Relapsed or Refractory Lymphomas | NCT02650999 | CD19+ Diffuse L... Follicular Lymp... Mantle Cell Lym... | Pembrolizumab | 18 Years - | Abramson Cancer Center at Penn Medicine |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
